(16384177), T. P. D., (16384180), K. W. E., (15107821), M. G. R., (16384183), M. Z., (16384186), Y. Q. R., (16384189), X. Z., . . . (10258780), F. M. (2025). Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
Lua i Stíl Chicago (17ú heag.)(16384177), Timothy P. DiPeri, et al. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. 2025.
Lua MLA (9ú heag.)(16384177), Timothy P. DiPeri, et al. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. 2025.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.